🔴 Indaptus Therapeutics is trading 10.64% down today amid stock-specific volatility and weaker U.S. indexes

Indaptus Therapeutics is trading at $3.57, down 10.64%, amid continued stock-specific volatility and weaker major U.S. indexes.

• No new company-specific announcement or direct catalyst was identified for September 23, 2026.
• The decline follows a 29.13% gain on September 22, alongside cautious risk sentiment.
• The September 8 private placement remains relevant dilution context, but is not a new September 23 catalyst.